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Methods for isolation of the ADP/ATP carrier (AAC) from yeast (Succharomyces cerevisiae) are described which allow 
separation of the carrier from the initially copurified porin which poses a specific problem in yeast. The procedure varies 
according to whether one wishes to obtain a stable CAT-AAC complex, the free and active AAC for reconstitution, or 
the SDS-denatured pure AAC peptide. CNBr cleavage of AAC enabled us to differentiate clearly between isogenes AAC- 
1 and AAC-2 recently found in yeast, due to the exclusive occurrence of a methionine (M-l 15) residue at the end of 
the first domain in AAC-2. Thus the AAC isolated from wild-type yeast is primarily or exclusively AAC-2. The isolated 
AAC is active in ADP/ATP exchange in reconsitituted liposomes with a V,,,,, of 1100 pmol/min per g protein and K,,, = 15 
,uM for ADP, and a Vmax of 900 mol/min per g protein and K,,, = 9 PM for ATP. 
ADP/ATP carrier; Cyanogen bromide cleavage; Reconstitution; (Succharomyces cerevisiue) 
1. INTRODUCTION 
Among eukaryotic cells, yeast is at present the 
most suitable target for molecular biological and 
genetic manipulations. Therefore, for applying 
molecular biological methods, the characterization 
and isolation of the ADP/ATP carrier (AAC) 
from Saccharomyces are desirable. Originally, in 
isolated mitochondria from Saccharomyces, func- 
tional properties of the AAC were studied [ 11, such 
as the exchange kinetics and inhibition by atrac- 
tylate. With procedures similar to those developed 
for bovine heart AAC [2], the isolation from yeast 
of two proteins of 37 and 34 kDa was reported [3]. 
The putative AAC of 37 kDa was separated by af- 
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finity chromatography. This molecular mass was 
considerably higher than found previously for the 
AAC from bovine heart and Neurospora. Also, 
the 37 kDa component was photoaffinity-labelled 
by arylazido-ADP [4]. The structural and func- 
tional properties of this protein were, however, not 
further characterized. Later, by genetic com- 
plementation of the yeast mutant opl, an AAC was 
found which migrated only with an apparent 
molecular mass of 30-32 kDa [5]. cDNA sequence 
analysis of this AAC gene then revealed a value of 
about 33 kDa [6]. However, it was recently shown 
that Saccharomyces contains another nuclear gene 
for the AAC, called AAC-2, which codes for a 
protein of 33.6 kDa [7]. 
In view of the fact that the isolation of the AAC 
from yeast and its molecular and functional 
characterization remained unsatisfactory, and in 
view of the vast potential for molecular, biological 
and genetic manipulation of the AAC in yeast, it 
was important to develop a highly efficient isola- 
tion procedure. Furthermore, functional charac- 
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terization of the isolated AAC after reincor- 
poration into liposomes was required. It should 
also be decided as to what extent the two different 
gene products, AAC-2 and AAC-1, are actually ex- 
pressed in the wild-type yeast. 
2. MATERIALS AND METHODS 
2.1. Cultivation of yeast ceils and preparation of mitochondria 
The haploid wild-type S. cerevisiae strain D 273-10B (Y was 
used. Yeast cells were grown in the usual synthetic culture 
medium with lactate as carbon source [8]. Mitochondria were 
isolated according to [8] with minor modifications. For isola- 
tion of intact AAC, 2 pmol CAT/mg protein and 50 CM ATP 
were added to the fresh mitochondria. For maximizing the yield 
of mitochondria, the cytochrome content of yeast cells was 
determined. On average, the cells contain 0.05 pmol/g (w/w) of 
cytochrome a/as. The purity of mitochondria was assayed by 
measuring the content of cytochrome a/as, usually amounting 
to 0.16 pmol/g protein. 
2.2. Isolation of AAC 
2.2.1. Isolation of intact AAC 
100 mg yeast CAT-preloaded mitochondria were incubated 
in 5 ml homogenizer buffer (150 mM NazS04, 0.5 mM EDTA, 
20 mM Tricine, 1 mM PMSF (pH 8.0); 1% TX-108 as detergent 
(detergent/protein, 1: l)]. PMSF was added to inhibit the high 
proteolytic activity in the detergent extracts. After 15 min in- 
cubation and ultracentrifugation at 100000 x g for 30 min the 
supernatant was applied to a hydroxyapatite column (6 x 2 cm) 
with an HTS-protein ratio of 200 $/mg and eluted with a buf- 
fer containing 0.1 M NaCl, 10 mM Mops, 0.1 mM EDTA, 
0.2070 Triton X-100 (pH 7.2). The AAC-containing fractions 
(80-170% of the column volume) were collected (protein con- 
centration 0.2 mg/ml) and concentrated by pressure dialysis to 
2 mg/ml. This concentrate was then applied to an S-300 column 
(80 x 0.8 cm) and eluted in 1.8-ml fractions per 8 min with the 
same buffer (flow rate 225 pl/min). 
2.2.2. High yield isolation of denatured AAC 
The first purification step is the same as that in section 2.2.1, 
except that a detergent/protein ratio of 2.5 : 1 was used. The 
combined AAC-containing fractions of the HTS column at 
0.7 mg protein/ml were concentrated by pressure dialysis to 
6 mg/ml. The S-308 column (130 x 0.6 cm) was run with the 
buffer used for intact AAC, with the addition of 1% SDS, and 
0.5-ml fractions were collected per 50 min (flow rate 
33 ,fJ/min). 
2.3. CNBr cleavage 
The purified AAC was incubated for 8 h in a CNBr/formic 
acid (8OVo) solution at 10 cg CNBr per pg protein (SOO-fold ex- 
cess with respect o methionines). The cleavage products were 
separated by a gel-electrophoresis system [9], most suitable for 
separation of small peptides. 
2.4. Reconstitution 
Transport activity of the yeast AAC was determined with 
minor modifications using the inhibitor stop method according 
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to [lo]. Purification has to be rapid in view of the instability of 
the unliganded yeast AAC and is carried out in batch procedure 
[ll]. Mitochondria were solubilized in 2% Triton X-100, 
150 mM Na2S04, 0.5 mM EDTA, 20 mM Tricine-NaOH (pH 
8.0) (10 mg protein/ml). The HTWprotein ratio was 
280pg/mg. Proteoliposomes were prepared by sonication of 
phospholipids (8% phosphatidylcholine, 2% phosphatidyleth- 
anolamine purified from egg yolk, 1% cholesterol) under addi- 
tion of AAC protein (100 rg/38 mg phospholipids) as in [lo]. 
Liposomal suspensions contained 70 mg phospholipids/ml and 
180~1~ protein/ml. External nucleotides were removed by 
Sephadex G-75 gel filtration. 
2.5. Exchange 
For transport measurements, liposomes were incubated with 
internal substrate (20 mM) in a buffer comprising 20 mM 
Tricine-NaOH (pH 7.5) at 25°C. The exchange was started by 
adding [%]ADP or [14C]ATP at 3.1, 9.5, 32.5 and 100 ,uM at 
t = 0 and stopped at t = 5, 10, 20, 30 s by addition of 3 mM 
CAT and 6 /LM BKA. The samples were passed through small 
Dowex anion-exchanger columns and the ratio of r4C-labelled 
ADP/ATP taken up was determined in the pass-through 
fraction. 
2.6. Preparation of antisera 
Polyvalent antibodies were produced in 3-month-old New 
Zealand rabbits by standard immunization procedures. 200 pg 
purified AAC in 1% SDS and 2 vols complete Freund’s adju- 
vant were injected subcutaneously three times over a period of 
8 weeks. Antisera were tested by routine ELISA. For im- 
munoblotting proteins were run on 12.5% Laemmli gels [12]. 
3. RESULTS 
3.1. Isolation and purification of the AAC 
For isolation of intact AAC, carboxyatractylate 
(CAT)-AAC or atractylate (ATR)-AAC complexes 
are usually the most suitable forms because of their 
stability. For this purpose, fresh yeast mitochon- 
dria were loaded with CAT or ATR. In 
preliminary purification experiments with Triton 
X-100 extracts from yeast mitochondria, after 
passage through hydroxyapatite, two major bands 
in the range 29-31 kDa were obtained. In view of 
the fact that two genes for the AAC have been 
found [7], it seemed at first feasible that these two 
bands represent he products of these two genes. 
For further identification, immunoreactivity 
against antiserum for the AAC from Neurospora 
crassa was tested in Western blots, which showed 
that only the band of 31 kDa was reactive. This 
suggested that the 29 kDa band might be 
mitochondrial porin which has been previously 
shown to have a molecular mass of 29 kDa in yeast 
[ 131. With antiserum against porin from 
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Neurosporu this assignment was confirmed. In ex- 
tracts from bovine heart, mitochondrial porin 
migrated more slowly than the AAC with an ap- 
parently greater molecular mass [14] and occurs in 
much lower amounts than in yeast and therefore 
caused no difficulty in the isolation of the AAC. 
The segregation of porin from the AAC in yeast 
required special measures. One way was to change 
the extraction conditions, in order to segregate 
porin from the AAC at an early stage. On varying 
the ratio of Triton X-100 to mitochondrial protein, 
it was noted that a major portion of the AAC 
could be extracted within a narrow range of 
detergent/protein ratios of 0.8-l .2 before signifi- 
cant solubilization of the lower molecular mass 
component (fig.lA). Also, after passing these ex- 
tracts through HTS at a Triton X-lOO/protein 
ratio = 1.4, the AAC could be obtained largely 
separated from the porin (fig.lB). 
For identification of the 31 kDa component 
with the AAC, the isolation procedure was per- 
formed with mitochondria loaded prior to isola- 
tion with [3H]CAT. Specific [3H]CAT binding 
increased lo-fold from the raw extract after the 
HTS pass-through, when the content of the 
29 kDa component was low at detergent/protein 
ratio = 1.2, and only &fold at a detergent/protein 
ratio = 3 with a greater content of this component. 
Further purification, particularly from higher 
molecular mass proteins, was achieved by gel 
filtration on S-300. More important is the removal 
during this step of the bulk of Triton X-100 and of 
phospholipids. The AAC-containing fractions 
were collected and concentrated by pressure 
dialysis. The final protein concentration was usual- 
ly 2-3 mg protein/ml containing Triton X-100/ 
protein at a ratio of about 10. With this method 
medium yields of pure CAT-AAC or ATR-AAC 
complexes can be obtained, suitable for structural 
and some functional studies. 
In order to prepare denatured AAC peptide in 
greater amounts, exhaustive xtraction of the AAC 
using higher Triton X-lOO/protein ratios of 
2-2.5: 1 is required. In this case, the hydrox- 
yapatite pass-through is significantly contaminated 
by porin. Separation of the AAC from porin can 
then be achieved by denaturing the HTS-protein 
with SDS and gel chromatography on S-300 
(fig.2). Porin is eluted with an apparently higher 
molecular mass than the AAC. Presumably, porin 
d/P 
d/P 
AAC 
Porin 
AAC 
Porin 
increasing detergent concentration )_ 
Fig.1. Extraction of the ADP/ATP carrier from yeast with 
increasing amounts of detergent. Partial segregation from the 
co-extracted porin. Gel electrophoresis of sediments of the 
corresponding extracts (A) and of the subsequent hydroxy- 
apatite pass-through fractions (B). Carboxyatractylate-loaded 
yeast mitochondria were extracted in batches of 6 mg in 0.8 ml 
buffer containing 0.5 mM NaCI, 0.1 mM EDTA and 10 mM 
Mops (pH 7.2) with increasing amounts of Triton X-100 
(detergent/protein wt ratio O-3) as indicated. Incubation for 
30 min at 4°C by shaking and subsequent centrifugation for 
40 min at 80000 x g. In separate xperiments the corresponding 
extracts were applied to small hydroxyapatite columns (3.1 x 
0.35 cm) with a buffer of 110 mM NaCI, 0.2% Triton X-100, 
0.1 mM EDTA, 10 mM Mops .(pH 7.2). The major protein 
pass-through fractions were concentrated and applied to SDS 
gel electrophoresis in a 12.5% acrylamide gel (B). 
forms trimers in SDS [151, whereas AAC exists as 
monomers [ 161. 
3.2. CNBr-cleavage pattern 
species 
One of the questions to 
identifies the AAC 
be solved with the 
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F eluted fractions 
Fig.2. Gel chromatography of the HTS pass-through fractions. 
(A) Chromatography on S-300 of CAT-AAC complex extracted 
using a limited Triton/protein ratio (d/p = 1). Higher 
molecular mass proteins and porin were separated. The elution 
profile indicates the impurities in the first AAC-containing 
fractions. Column was run with the buffer used in fig.1. (B) 
Chromatography of SDS-denatured extracts obtained at higher 
Triton X-lOO/protein ratio (d/p = 2.5). Large amounts of 
essentially pure AAC and porin peptide were obtained by using 
the elution buffer in fig.1 supplemented with 1% SDS. Flow 
rate was decreased IO-fold compared with A. 
purified AAC is to what extent the two genes of 
AAC found in yeast are expressed in the wild-type 
S. cerevisiae. The amino acid sequence decoded 
from the cDNA shows that AAC-2 is distinguished 
by a methionine occurring after about the first 
third of the sequence [7]. In this respect, AAC-2 
differs not only from AAC-1 but also from AAC 
in all other species currently known, where a 
methionine occurs only after two thirds of the se- 
quence. The CNBr-cleavage pattern of AAC-2 
should therefore clearly differ from that of 
AAC-I . Fortunately, the degree of CNBr cleavage 
for the yeast AAC can reach a very high value and 
therefore the CNBr-cleavage pattern is rather sim- 
ple. This is compared with peptides of the AAC on 
the basis of the calculated molecular mass (fig.3). 
In order to ensure that the identity of the AAC 
fragments was different from that of porin, we 
also cleaved purified porin. Most prominent is a 
peptide of about 10 kDa which cannot be iden- 
tified with any cleavage product of the hitherto 
known AAC-1. It can only be identified with the 
fifth CNBr fragment as predicted from the recently 
discovered AAC-2 gene product. In fact, scrutiny 
of the cleavage pattern shows that virtually all pep- 
tides can be explained as being cleavage products 
Fig.3. CNBr-cleavage pattern of purified AAC and, for 
comparison, of the porin from yeast. The two proteins were 
obtained and separated by gel chromatography on S-300 in 
SDS-containing buffer. The lower resolution of the low 
molecular mass AAC2 CNBr fragments is due to the higher 
amount of phospholipids in the AAC fractions. CNBr 
fragments of horse heart myoglobin were used as molecular 
mass standards. The AAC cleavage pattern is compared with 
the predicted CNBr fragments of the AAC-2 gene product 171 
and of porin [17]. 
of the AAC-2, as calculated from the AAC-2 se- 
quence. 
3.3. Reconstitution of transport activity with 
isolated AAC in liposomes 
A major goal in isolating the AAC is also study- 
ing its function. For this purpose, however, the 
AAC cannot be isolated in the stable CAT-AAC 
complex, but only in the free form which is much 
more labile. The rapid procedure developed for 
this purpose for the AAC from beef heart [lo] was 
with corresponding modifications also applied to 
the AAC from yeast. Since the yield of AAC is too 
low at a Triton X-lOO/protein ratio = 1, this ratio 
was increased to 2 for this batch procedure by 
allowing for a less pure preparation. The superna- 
tant from these centrifuged HTS mixtures could be 
incorporated into liposomes according to the 
method published for bovine heart AAC [lo]. 
For studying the kinetics of ADP/ATP ex- 
change, 14C-labelled ATP or ADP was added to 
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Fig.4. Concentration dependence of ADP (A) or ATP (B) exchange in proteoliposomes obtained by reincorporation of purified AAC 
into phospholipid vesicles. Determination of V ,,,= and Km of adenine nucleotide uptake from plots according to Eadie Hofstee. Initial 
exchange velocities were obtained from at least 4 inhibitor-stopped samples, at time intervals of 5, 10, 20 and 30 s. 
ADP- or ATP-loaded AAC-containing pro- 
teoliposomes. The rate of uptake of radioactivity 
corresponds to exchange against endogenous 
unlabeled nucleotides. In fig.4 the results of the ex- 
change rates as a function of the concentration of 
ADP and ATP are plotted according to Eadie 
Hofstee for evaluation of the maximum exchange 
rates and K,,, values. From the approximately 
linear relation, maximum rates @mol/min per g 
protein) of 1100 for ADP or 900 for ATP were ex- 
trapolated. The K, value is about 15 PM for ADP 
and 9 gM for ATP. The rates are somewhat 
greater than those determined for reconstituted 
bovine AAC under optimal conditions. We can 
conclude that the isolated AAC is active and com- 
petent in ADP/ATP exchange. 
3.4. Antisera 
Antisera against the ADP/ATP carrier were 
raised in rabbits. For immunization, the isolated 
yeast AAC was prepared by gel chromatography 
on an S-300 gel column, using SDS as detergent. 
The antibodies were obtained by the footpad im- 
munisation boosting procedure after the first com- 
plete adjuvant-mediated injection of SDS-AAC. 
The antiserum has a surprisingly high specificity 
for yeast AAC and cross-reacts only very poorly 
with mammalian AAC and even Neurospora AAC 
(fig.5). This is surprising in view of the fact that 
the antiserum against Neurospora AAC cross- 
reacts quite well with yeast AAC. The titer of the 
serum was determined by ELISA and shown to 
decrease to 10% of the maximum only at a dilution 
of more than 1:6000. Thus, for immunoblot ap- 
plications the serum was applied in a dilution of 
1:4000. 
Neurospora Yeast Bovine 
crassa heart kidney 
AAC Mito AAC Mito AAC Mito AAC Mito 
Fig.5 Immunoblots with antiserum raised against the purified 
AAC from yeast tested against AAC from various sources. For 
immuno-detection polyvalent antisera to AAC from yeast were 
diluted I :4000. Each lane of the blotted gel contained 
equivalent amounts of mitochondrial protein (30 pg) or purified 
AAC-protein (5 pg). 
431 
Volume 244, number 2 FEBS LETTERS February 1989 
4. DISCUSSION 
The now classical procedures for the isolation of 
AAC from mitochondria can also be applied to the 
isolation of AAC from yeast when properly 
modified. The major problem is obviously removal 
of the porin which tends to accompany the AAC 
during the hydroxyapatite step. Previously, 
separation of the ‘37 kDa’ species from ‘34 kDa’ 
component was achieved only by affinity 
chromatography on an ATR-liganded column [3]. 
However, in most cases, affinity chromatography 
has the disadvantages of giving low yields of AAC 
and of denaturation by the adsorption procedure. 
The present isolation procedure therefore provides 
a means for future work on isolating the AAC 
from AAC mutants as well, whether generated by 
selection, gene disruption or site-directed 
mutagenesis. This is also particularly important 
for reconstitution of the unloaded AAC in order to 
study the functional differences of the AAC wild 
or mutant forms. 
The higher molecular masses, as reported 
previously [3] of 37 and 34 kDa for the two com- 
ponents partially purified from yeast mitochondria 
are not easily explained. The 37 kDa component 
was identified by affinity chromatography of the 
AAC, photoaffinity-labelled with arylazido-ADP 
[3] and arylazido-ATR [4]. Comparison of the 
reported amino acid composition of the 37 kDa 
component with the now decoded sequence from 
the AAC2 cDNA reveals some significant dif- 
ferences (especially His, Met). With hindsight, 
there was probably only a calibration error of the 
AAC, since, as first shown by genetic complemen- 
tation, followed by cDNA analysis and now with 
the isolated AAC, the apparent molecular mass of 
the AAC is only at 31 kDa. 
The isolation of primarily or exclusively only 
one of the two possible gene products from yeast, 
of the AAC-2, could be convincingly demonstrated 
here by the CNBr-cleavage pattern of the purified 
protein. The occurrence of only a single band con- 
firmed by the immunoblots also agrees with a 
single type of AAC. This is in accordance with 
results indicating that only the AAC-2 gene can 
complement he opl mutation with a single copy 
whereas complementation with the AAC-1 gene re- 
quires multiple copies. 
The existence of two AAC genes in yeast and the 
present finding that primarily or exclusively the 
AAC-2 protein is functionally active in aerobically 
grown yeast cells, raises the question of whether 
the two isoforms are adapted to different re- 
quirements of yeast metabolism and are differently 
expressed during the life cycle. It remains to be 
ascertained in further investigations whether there 
is a dynamic change of isoform pattern. 
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